Colitis grave inmunomediada por Nivolumab-Ipilimumab: a propósito de un caso by Maria Victoria Foglino, Ayelen Vacirca, Florencia Cabrera, Ignacio Gutierrez Magaldi, Santiago Rafael Bella

Subjects: Get full text

Anti-CTLA-and anti-PD-1 immune checkpoint inhibitor antibodies impair human sperm motility in-vitro by Ilaria Cosci, Luca De Toni, Paolo Del Fiore, Andrea Di Nisio, Andrea Di Nisio, Samuela Carraro, Claudia Maria Radu, Loris Bertazza, Simone Mocellin, Simone Mocellin, Jacopo Pigozzo, Giovanna Crivellaro, Marina Coppola, Alberto Ferlin

Subjects: “…ipilimumab…”
Get full text

Disproportionality analysis of adverse events associated with ipilimumab and nivolumab combination therapy based on FAERS database by Xianyu Dai, Hongliang Cao, Jiajun Li, Tao Zhang, Yuchuan Hou

Subjects: “…Ipilimumab…”
Get full text

Plasma protein dynamics during ipilimumab treatment in metastatic melanoma: associations with tumor response, adverse events and survival by Ragnhild Reehorst Lereim, Claire Dunn, Elin Aamdal, Sudhir Kumar Chauhan, Oddbjørn Straume, Tormod Kyrre Guren, Jon Amund Kyte

Subjects: Get full text

Combatting mucosal melanoma: recent advances and future perspectives by Helen Tyrrell, Miranda Payne

Subjects: Get full text

Pathologic complete response after laparoscopic surgery following treatment with nivolumab and ipilimumab for anticancer drug-resistant MSI-high descending colon cancer: a case rep... by Hiroshi Sawayama, Yuji Miyamoto, Katsuhiro Ogawa, Mayuko Ohuchi, Yuki Hisano, Moeko Kato, Hiroki Tubakihara, Naoya Yoshida, Hideo Baba

Subjects: Get full text

Hypophysitis induced by immune checkpoint inhibitors in a Scottish melanoma population by Khor Zhong Wei, Mark Baxter, Richard Casasola

Subjects: Get full text

Neoadjuvant immunotherapy with ipilimumab/nivolumab induces a complete response of a primary malignant melanoma in an 89 years old patient by Pascal Spahn, Torsten Schweiger, Andreas Buchholz, Claus-Detlev Klemke

Subjects: Get full text

NAVIGATING IPILIMUMAB-INDUCED HYPOPHYSITIS IN ADVANCED HEPATOCELLULAR CARCINOMA: A CLINICAL PERSPECTIVE by Luis Carlos Afonso Rocha, Cecília Moreira, Filipe Breda, José Presa

Subjects: Get full text

Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan by Tomoki Taniguchi, Koji Iinuma, Kei Kawada, Takashi Ishida, Kimiaki Takagi, Masayuki Tomioka, Makoto Kawase, Kota Kawase, Keita Nakane, Yuki Tobisawa, Takuya Koie

Subjects: Get full text

Retreatment With Nivolumab and Ipilimumab in Pleural Mesothelioma Following Disease Progression After a Durable Response: Case Series by Illaa Smesseim, MD, Paul Baas, MD, PhD, Jacobus A. Burgers, MD, PhD

Subjects: Get full text

Re-exposition to ipilimumab plus nivolumab in metastatic Merkel cell carcinoma by Valerie Glutsch, Patrick Schummer, Matthias Goebeler, Anja Gesierich, Bastian Schilling, Bastian Schilling

Subjects: Get full text

The burden and clinical trajectory of immune checkpoint inhibitor-induced endocrinopathies: an 8-year experience by Fateen Ata, Adeel Ahmad Khan, Emad Algorani, Amr Faisal Musaed Alsharafi, Reham Abo Shdid, Mohammad Nofal, Ayman R. Ibrahim, Loai Abdullah, Khalil Youssef El Annan, Tareq Emad Hawash Al-Bkoor, Kakil Ibrahim Rasul, Tarik Elhadd, Haval Surchi

Subjects: Get full text

Real-world effectiveness and safety of first-line chemoimmunotherapy combinations in metastatic non-small cell lung cancer with programmed death ligand-1 < 50%: results from an Ita... by Alessandro Inno, Antonello Veccia, Ettore D’Argento, Floriana Morgillo, Elio Gregory Pizzutilo, Fabiana Vitiello, Alberto Pavan, Fiorella Lombardo, Marco Russano, Vincenzo Sforza, Francesca Colamartini, Carlo Genova, Rita Chiari, Antonella Cristofano, Alessandro Delconte, Emanuela Vattemi, Alessandra Dessi, Daniele Galanti, Simona Busato, Giovanni Palazzolo, Clementina Savastano, Antonio Bianco, Francesco Verderame, Cristina Mazzi, Fabiana Marchetti, Stefania Kinspergher, Denis Occhipinti, Carminia Maria Della Corte, Daniele Piscazzi, Marina Gilli, Emilio Bria, Orazio Caffo, Stefania Gori

Subjects: Get full text

Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment by Sabine Schmid, MD, Lisa Holer, MSc, Katrin Gysel, MSc, Kira-Lee Koster, MD, Sacha I. Rothschild, MD, Laura A. Boos, MD, Lorenz Frehner, MD, Sabine Cardoso Almeida, MD, Christian Britschgi, MD, PhD, Yannis Metaxas, MD, Michael Mark, MD, Patrizia Froesch, MD, Wolf-Dieter Janthur, MD, Anna Allemann, MD, Christine Waibel, MD, Catherine Von der Mühll-Schill, MD, Martin Früh, MD, Laetitia A. Mauti, MD, PhD

Subjects: Get full text

An update on adjuvant systemic therapies in melanoma by Evangeline Samuel, Maggie Moore, Mark Voskoboynik, Mark Shackleton, Andrew Haydon

Subjects: Get full text

Two cases of Stevens-Johnson syndrome presenting severe ocular complications associated with immune checkpoint inhibitor by Yukiko Nakahara-Omori, Yukiko Nakahara-Omori, Yukari Kobayashi, Sumiko Ishizaki, Kyoko Chujo, Chikako Suto, Masaru Tanaka, Noriko Umegaki-Arao

Subjects: Get full text

Nivolumab and ipilimumab therapy in a patient with non-small cell lung cancer with chronic kidney disease by Hiroaki Satoh, Sou Hattori

Subjects: Get full text

First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer by Roman M. Shapiro, Michal Sheffer, Matthew A. Booker, Michael Y. Tolstorukov, Grace C. Birch, Moshe Sade-Feldman, Jacy Fang, Shuqiang Li, Wesley Lu, Michela Ansuinelli, Remy Dulery, Mubin Tarannum, Joanna Baginska, Nishant Dwivedi, Ashish Kothari, Livius Penter, Yasmin Z. Abdulhamid, Isabel E. Kaplan, Dinh Khanhlinh, Ravindra Uppaluri, Robert A. Redd, Sarah Nikiforow, John Koreth, Jerome Ritz, Catherine J. Wu, Robert J. Soiffer, Glenn J. Hanna, Rizwan Romee

Subjects: Get full text

Eosinophil is a predictor of severe immune-related adverse events induced by ipilimumab plus nivolumab therapy in patients with renal cell carcinoma: a retrospective multicenter co... by Yoshihiko Tasaki, Shuzo Hamamoto, Shimpei Yamashita, Junya Furukawa, Kazutoshi Fujita, Ryotaro Tomida, Makito Miyake, Noriyuki Ito, Hideto Iwamoto, Yoshihisa Mimura, Yosuke Sugiyama, Rei Unno, Atsushi Okada, Takahiro Yasui, Yoko Furukawa-Hibi

Subjects: Get full text